Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Adenosine 5'-triphosphate-sensitive potassium (KATP) channel is a complex protein that functions as a metabolic sensor, coupling cellular energy status to membrane electrical activity [PubMed, PMC2664614]. It is a hetero-octameric complex composed of four pore-forming inwardly rectifying potassium channel subunits (Kir6.1 or Kir6.2) and four regulatory sulfonylurea receptor subunits (SUR1, SUR2A, or SUR2B) [UniProt, P48549]. In pancreatic beta cells, the channel closes in response to high ATP/ADP ratios, leading to membrane depolarization and the secretion of insulin. Conversely, in cardiac and vascular smooth muscle, these channels open during metabolic stress to protect cells from calcium overload and manage vascular resistance [PubMed, PMC4212513]. Mutations in the genes encoding these subunits, such as KCNJ11 and ABCC8, are linked to metabolic disorders like neonatal diabetes and hyperinsulinism. Because of their pivotal role in physiology, they are primary therapeutic targets for sulfonylureas in diabetes management and various vasodilators for cardiovascular conditions.
KATP channel blockers (e.g., sulfonylureas) bind to the SUR subunit, closing the pore to induce membrane depolarization and insulin release, while KATP channel openers (e.g., diazoxide, minoxidil) promote channel opening to cause hyperpolarization and reduce cellular excitability [StatPearls, NBK557602].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine 5'-triphosphate-sensitive potassium channel (KATP channel).